Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.
Papadopoulou A, Karavalakis G, Papadopoulou E, Xochelli A, Bousiou Z, Vogiatzoglou A, Papayanni PG, Georgakopoulou A, Giannaki M, Stavridou F, Vallianou I, Kammenou M, Varsamoudi E, Papadimitriou V, Giannaki C, Sileli M, Stergiouda Z, Stefanou G, Kourlaba G, Gounelas G, Triantafyllidou M, Siotou E, Karaglani A, Zotou E, Chatzika G, Boukla A, Papalexandri A, Koutra MG, Apostolou D, Pitsiou G, Morfesis P, Doumas M, Karampatakis T, Kapravelos N, Bitzani M, Theodorakopoulou M, Serasli E, Georgolopoulos G, Sakellari I, Fylaktou A, Tryfon S, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: vogiatzoglou a. Nat Med. 2023 Aug;29(8):2019-2029. doi: 10.1038/s41591-023-02480-8. Epub 2023 Jul 17. Nat Med. 2023. PMID: 37460756 Clinical Trial.
Nursing home elderly patients hospitalized for COVID-19: Characteristics and predictors of outcomes.
Verykokou G, Apollonatou V, Papaioannou AI, Vogiatzoglou A, Roukas K, Kyriakopoulos C, Chronis C, Aggelopoulou C, Gundogdu D, Schoini P, Chloros D, Kavatha D, Manali ED, Papiris SA, Tsoukalas G, Kostikas K, Fouka E, Boumpas D, Loukides S. Verykokou G, et al. Among authors: vogiatzoglou a. Geriatr Gerontol Int. 2023 Jan;23(1):62-64. doi: 10.1111/ggi.14521. Epub 2022 Dec 7. Geriatr Gerontol Int. 2023. PMID: 36479800 Free PMC article. No abstract available.
Evaluation of (-)-epicatechin metabolites as recovery biomarker of dietary flavan-3-ol intake.
Ottaviani JI, Fong R, Kimball J, Ensunsa JL, Gray N, Vogiatzoglou A, Britten A, Lucarelli D, Luben R, Grace PB, Mawson DH, Tym A, Wierzbicki A, Smith AD, Wareham NJ, Forouhi NG, Khaw KT, Schroeter H, Kuhnle GGC. Ottaviani JI, et al. Among authors: vogiatzoglou a. Sci Rep. 2019 Sep 11;9(1):13108. doi: 10.1038/s41598-019-49702-z. Sci Rep. 2019. PMID: 31511603 Free PMC article.
Flavonoid intake in European adults (18 to 64 years).
Vogiatzoglou A, Mulligan AA, Lentjes MA, Luben RN, Spencer JP, Schroeter H, Khaw KT, Kuhnle GG. Vogiatzoglou A, et al. PLoS One. 2015 May 26;10(5):e0128132. doi: 10.1371/journal.pone.0128132. eCollection 2015. PLoS One. 2015. PMID: 26010916 Free PMC article.
Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk).
Vogiatzoglou A, Mulligan AA, Bhaniani A, Lentjes MAH, McTaggart A, Luben RN, Heiss C, Kelm M, Merx MW, Spencer JPE, Schroeter H, Khaw KT, Kuhnle GGC. Vogiatzoglou A, et al. Free Radic Biol Med. 2015 Jul;84:1-10. doi: 10.1016/j.freeradbiomed.2015.03.005. Epub 2015 Mar 17. Free Radic Biol Med. 2015. PMID: 25795512 Free PMC article.
16 results